- Home
- MKL
as 05-09-2025 10:40am EST
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.
| Founded: | 1930 | Country: | United States |
| Employees: | N/A | City: | GLEN ALLEN |
| Market Cap: | 22.1B | IPO Year: | 1986 |
| Target Price: | $1702.20 | AVG Volume (30 days): | 60.5K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 135.94 | EPS Growth: | -26.41 |
| 52 Week Low/High: | $1491.03 - $2063.68 | Next Earning Date: | 04-30-2025 |
| Revenue: | $15,553,213,000 | Revenue Growth: | -6.46% |
| Revenue Growth (this year): | -6.65% | Revenue Growth (next year): | 4.44% |
Stock Insider Trading Activity of Markel Group Inc. (MKL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MARKEL STEVEN A | MKL | Director | Feb 25 '25 | Sell | $1,870.85 | 1,054 | $1,973,938.71 | 62,668 | |
| MARKEL STEVEN A | MKL | Director | Feb 24 '25 | Sell | $1,858.22 | 1,146 | $2,129,825.14 | 62,668 | |
| MARKEL STEVEN A | MKL | Director | Feb 21 '25 | Sell | $1,857.72 | 800 | $1,485,440.06 | 62,668 |
Latest Markel Group Inc. News
MKL Breaking Stock News: Dive into MKL Ticker-Specific Updates for Smart Investing
Life Insurance International
a day ago
Markel unveils new insurance product for clinical trials
MT Newswires
2 days ago
Markel Group Insider Sold Shares Worth $750,976, According to a Recent SEC Filing
PR Newswire
2 days ago
Markel Group announces redemption of Series A Preferred Shares
CNW Group
2 days ago
Markel Group announces redemption of Series A Preferred Shares
Insider Monkey
2 days ago
Markel Group Inc. (MKL): A Bull Case Theory
PR Newswire
2 days ago
Markel launches Clinical Trials products to support clinical trials research, globally
Simply Wall St.
5 days ago
Is Markel Group Inc.'s (NYSE:MKL) Latest Stock Performance A Reflection Of Its Financial Health?
Morningstar Research
7 days ago
Analyst Report: Markel Group Inc.
Compare MKL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MKL Markel Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.